Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
2005

Early Hemoperfusion with Polymyxin B Improves Lung Function in Sepsis

Sample size: 36 publication Evidence: moderate

Author Information

Author(s): Kushi Hidehiko, Miki Takahiro, Okamoto Kazuhiko, Nakahara Jun, Saito Takeshi, Tanjoh Katsuhisa

Primary Institution: Nihon University School of Medicine

Hypothesis

The inhibitory effect of PMX on activation of chemokines, neutrophils, and vascular endothelial cells is associated with improvement in the PaO2/FiO2 ratio.

Conclusion

DHP-PMX significantly decreased blood levels of PAI-1, NE, and IL-8, and significantly improved the PaO2/FiO2 ratio.

Supporting Evidence

  • All patients remained alive after 1 month.
  • The mean blood levels of PAI-1, NE, and IL-8 were significantly decreased from 48 hours after the start of DHP-PMX treatment.
  • The mean PaO2/FiO2 ratio was significantly improved from 96 hours after the start of DHP-PMX treatment.
  • There were significant negative correlations between the PaO2/FiO2 ratio and blood levels of NE and IL-8.

Takeaway

This study found that a treatment called DHP-PMX helps sick patients breathe better by cleaning harmful substances from their blood.

Methodology

Thirty-six patients with sepsis underwent DHP-PMX treatment, and levels of various mediators and the PaO2/FiO2 ratio were measured before and after treatment.

Potential Biases

The study design does not allow for definitive conclusions about causality due to lack of control group.

Limitations

This was a prospective uncontrolled observational study with a limited number of patients.

Participant Demographics

Patients were aged 28-85 years, with 21 men and 15 women.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/cc3815

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication